Delivery Order SPE2DB25D3020-SPE2DB25FWHUD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,370.31 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 with a ceiling value of $11,287.97. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The contract is set to be completed by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,694.04 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units. This firm fixed-price contract was awarded on June 24, 2025, with an ultimate completion date of June 25, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $11,943.31. This delivery order represents a firm fixed price contract with a completion date of September 12, 2025, and is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Modafinil 100 mg tablets (30-count units) on June 2, 2025, with a ceiling value of $3,507.66. This firm fixed-price delivery order, which is expected to be completed by June 3, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition without set-aside designation, reflecting the vendor's established capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,563.97 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which carries a potential...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $19,087.50. This non-competitive delivery order, valued through September 30, 2025, represents a continuation of pharmaceutical support services through AmerisourceBergen's existing federal contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,060.52 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units. The contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,306.88 for 30-count tablets of Modafinil 100 mg, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, for the supply of Modafinil 100 mg tablets (30-count units) with a ceiling value of $8,420.09. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWHUDDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,552.25 for 100 mg Modafinil tablets (30-count package) on May 29, 2025, with completion scheduled for May 30, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1.0 billion through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. This particular delivery order for Modafinil—a wakefulness-promoting medication commonly used in military and federal healthcare settings—reflects the company's ongoing role in fulfilling pharmaceutical needs across the Defense Logistics Agency's medical supply chain. The SPE2DX IDC enables the contractor to provide diverse therapeutic products including specialty medications, brand-name and generic drugs, and medical supplies to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's significance as a pharmaceutical vendor within the federal healthcare ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 5/29/25 |